Related Experiment Video

Updated: Jun 28, 2026

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
09:06

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice

Published on: February 20, 2019

Vaccines in development to prevent and treat atherosclerotic disease

Elizabeth Riley1, Vijaya Dasari, William H Frishman

  • 1Departments of Medicine, University of Colorado Health Sciences Center, Denver, Colorado, USA.

Cardiology in Review
|October 17, 2008
PubMed

Insights

New vaccines targeting immune mechanisms show promise in preventing coronary heart disease (CHD) and atherosclerosis. These innovative vaccines aim to reduce inflammation and modify risk factors, offering potential atheroprotective benefits.

Area of Science:

  • Cardiovascular Medicine
  • Immunology
  • Vaccinology

Background:

  • Coronary heart disease (CHD) is a leading cause of mortality in the US.
  • Immune mechanisms are increasingly recognized in the pathogenesis of atherosclerosis.
  • Pro-inflammatory substances like heat shock proteins and oxidized low-density lipoprotein are implicated in plaque development.

Purpose of the Study:

  • To review current and developing vaccines targeting immune pathways in atherosclerosis.
  • To explore the potential atheroprotective effects of various vaccine modalities.
  • To assess vaccines as novel therapeutic options for CHD.

Main Methods:

  • Review of scientific literature on vaccines and their role in cardiovascular disease.
  • Analysis of immune targets in atherosclerosis, including heat shock proteins and cholesteryl ester transfer protein.
  • Examination of anti-inflammatory effects of existing and novel vaccines.

Main Results:

  • Vaccines targeting heat shock proteins and oxidized low-density lipoprotein are under development.
  • A vaccine inhibiting cholesteryl ester transfer protein has been developed.
  • The influenza vaccine demonstrates an atheroprotective effect, highlighting the role of vaccination in cardiovascular health.

Conclusions:

  • Vaccines targeting specific immune mechanisms and risk factors offer a promising new strategy for atheroprotection.
  • Nicotine, antiangiotensin, and anti-obesity vaccines may play a therapeutic role in managing atherosclerosis.
  • Vaccines represent a potential addition to the therapeutic armamentarium against cardiovascular disease.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...